Purpose: Hyponatremia ([plasma sodium] <135 mmol.L-1) is a potentially seri
ous complication of ultraendurance sports. However, the etiology of this co
ndition is still uncertain. This observational cohort study aimed to determ
ine prospectively the incidence and etiology of hyponatremia in an ultradis
tance triathlon. Methods: The subjects consisted of 605 of the 660 athletes
entered in the New Zealand Ironman triathlon (3.8-km swim, 180-km cycle, a
nd 42.2-km run). Subjects were weighed before and after the race. A blood s
ample was drawn for measurement of plasma sodium concentration after the ra
ce. Results: Complete data on pre- and postrace weights and plasma sodium c
oncentrations were available in 330 race finishers. Postrace plasma sodium
concentrations were inversely related to changes in body weight (P = 0.0001
). Women (N = 38) had significantly lower plasma sodium concentrations (133
.7 vs 137.4 mmol.L-1; P = 0.0001) than men (N = 292) and lost significantly
less relative weight (-2.7 vs -4.3%; P = 0.0002). Fifty-eight of 330 race
finishers (18%) were hyponatremic; of these only 18 (31%) sought medical ca
re for the symptoms of hyponatremia (symptomatic). Eleven of the 58 hyponat
remic athletes had severe hyponatremia ([plasma sodium] <130 mmol.L-1); sev
en of these ii severely hyponatremic athletes were symptomatic. The relativ
e body weight change of the 11 severely hyponatremic athletes ranged from -
2.4% to +5%; eight (73%) of these athletes either maintained or gained weig
ht during the race. In contrast, relative body weight changes in the 47 ath
letes with mild hyponatremia ([plasma sodium] 130-134 mmol.L-1) were more v
ariable, ranging from -9.25% to +2.2%. Conclusions: Hyponatremia is a commo
n biochemical finding in ultradistance triathletes but is usually asymptoma
tic. Although mild hyponatremia was associated with variable body weight ch
anges, fluid overload was the cause of most (73%) cases of severe, symptoma
tic hyponatremia.